Biomarker Technologies LLC To Present At 10th Annual International Pharma & Biotech Licensing Summit
10/19/2005 5:12:59 PM
PHOENIX--(BUSINESS WIRE)--March 10, 2005--Biomarker Technologies, the worldwide licensor of the blood diagnostic test for the early detection of breast cancer called the BT Test(TM), announced today that William Gartner, president and CEO, will participate in the Strategic Research Institute's 10th Annual International Pharma & Biotech Licensing Deal-Making Summit at Doubletree Paradise Valley Resort in Scottsdale, Ariz. The Summit is taking place March 29-31, 2005.
Gartner will serve as a panelist addressing the volatile increases and decreases in the small and mid-cap biotech, diagnostic, and device market. The panel will also invoke past experiences as a look to the 2005 forecast. Gartner will present a newly conceived valuation tool developed by F. Randall Grimes at Biomarker Technologies headquarters. The Excel(R) data-graph macro allows strategic "what-if" evaluations to be performed simply by inputting estimated values. The peak ROI and per-share valuations can then be seen graphically.
comments powered by